X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.03
Delayed Data
As of May 21
 0.00 / 0.00%
Today’s Change
1.55
Today|||52-Week Range
5.00
+2.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues596.8K387.4K282.3K0.00
 
 
 
 
Cost of Goods Sold139.3K104.0K108.2K0.00
 
 
 
 
Depreciation And Amortization20.3K11.2K10.8K--
 
 
 
 
 
Operating ExpensesGross Income437.2K272.2K163.3K0.00
 
 
 
 
General Expenses1.2M865.6K649.3K619.1K
 
 
 
 
 
Other Operating Expenses0.000.00-0.000.00
 
 
 
Research And Development50.8K40.8K42.3K143.8K
 
 
 
 
 
Total Operating Expenses1.4M980.8K768.3K619.1K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-765.6K-593.4K-486.0K-619.1K
 
 
 
 
 
Extraordinary Charge---143.8K--0.00
 
 
Other Expenses-8.1K13.3K-72.8K-102.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-773.7K-723.9K-558.8K-721.7K
 
 
 
 
 
Minority Interest-76.3K-149.9K-57.1K-52.2K
 
 
 
 
 
Discontinued Operations0.000.000.00-115.4K
 
 
Net Income-697.5K-574.0K-501.7K-784.9K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.4M11.8M11.9M11.6M
 
 
 
 
 
Shares To Calculate EPS Diluted11.4M11.8M11.9M11.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.04-$0.04-$0.06
 
 
 
 
 
EPS Diluted-$0.06-$0.04-$0.04-$0.07
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account